Saba Capital Management, L.P. - DEEP MEDICINE ACQUISITION CO ownership

DEEP MEDICINE ACQUISITION CO's ticker is and the CUSIP is 243733110. A total of 33 filers reported holding DEEP MEDICINE ACQUISITION CO in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Saba Capital Management, L.P. ownership history of DEEP MEDICINE ACQUISITION CO
ValueSharesWeighting
Q3 2023$73,491
+105.3%
210,5760.0%0.00%
+100.0%
Q2 2023$35,798
+17.2%
210,5760.0%0.00%0.0%
Q1 2023$30,555
+107.3%
210,5760.0%0.00%
Q4 2022$14,740
+110.6%
210,5760.0%0.00%
Q3 2022$7,000
-73.1%
210,5760.0%0.00%
Q2 2022$26,000
-31.6%
210,5760.0%0.00%
-100.0%
Q1 2022$38,000
-52.5%
210,576
-15.8%
0.00%0.0%
Q4 2021$80,000250,0760.00%
Other shareholders
DEEP MEDICINE ACQUISITION CO shareholders Q3 2022
NameSharesValueWeighting ↓
Tuttle Capital Management, LLC 69,024$22,0000.03%
COWEN AND COMPANY, LLC 1,081,251$346,0000.03%
Yakira Capital Management, Inc. 750,000$240,0000.03%
MANGROVE PARTNERS IM, LLC 1,500,000$480,0000.03%
Owl Creek Asset Management, L.P. 750,000$240,0000.02%
K2 PRINCIPAL FUND, L.P. 475,000$152,0000.01%
Mint Tower Capital Management B.V. 194,190$62,0000.01%
SkyView Investment Advisors, LLC 100,000$32,0000.01%
HGC Investment Management Inc. 300,000$96,0000.01%
Context Capital Management, LLC 198,000$63,0000.01%
View complete list of DEEP MEDICINE ACQUISITION CO shareholders